Quidel Corp (QDEL) Prelim. Q2 Revenue Tops Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. SPY
5. INTC
6. META
7. AAPL
8. JBLU
9. ANT
10. NVDA

Go back to Quidel Corp (QDEL) Prelim. Q2 Revenue Tops Consensus

Quidel Announces Preliminary Revenue for Second Quarter 2020

July 6, 2020 5:00 PM EDT

SAN DIEGO--(BUSINESS WIRE)-- Quidel Corporation (NASDAQ: QDEL) (Quidel), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it expects revenues in the second fiscal quarter of 2020 to be in the range of $201 million to $202 million, an increase of approximately 86% - 87% over the prior year quarter.

Our second quarter was even stronger than we had expected, driven by demand for our COVID-19 Molecular Diagnostics and Rapid Immunoassay products. With the rapid development, EUA clearance, and production of over 3 million Lyra® SARS-CoV-2 and Lyra® Direct... More